Suppr超能文献

足月患者单次宫颈内应用前列腺素E2粘性凝胶进行宫颈成熟及引产。

Ripening of the cervix and induction of labor in patients at term by single intracervical application of prostaglandin E2 in viscous gel.

作者信息

Wingerup L, Andersson K E, Ulmsten U

出版信息

Acta Obstet Gynecol Scand Suppl. 1979;84:11-4. doi: 10.3109/00016347909156815.

Abstract

Prostaglandin E2 (PGE2) suspended in a viscous gel was deposited intracervically to 115 patients at term with an unripe cervix. 45 of these patients were given a single dose of 1.0 mg PGE2, whereas the remaining 70 received only half that dose, i.e. 0.5 mg. Irrespective of dose greater than 60 per cent of the patients were induced into labor and delivered without further stimulation within less than 24 hours. The mean induction delivery time was 10 hours. In the remaining patients a considerable ripening of the cervix was registered. Hypercontractility did occur in one patient given 1.0 mg PGE2, otherwise no maternal side effects were observed. There were no adverse effects on the fetuses. The number of instrumental deliveries was 19 per cent including 9 per cent cesarean sections. It is concluded that locally applied PGE2-gel can be used to produce ripening of the cervix and/or induce labor in patients at term with an unripe cervix. Since there was practically no difference in efficiency between the two doses but one case of hyperstimulation in patients given 1.0 mg PGE2, the smaller dose, i.e. 0.5 mg is recommended.

摘要

将悬浮于粘性凝胶中的前列腺素E2(PGE2)经宫颈内给予115名足月宫颈未成熟的患者。其中45名患者给予单剂量1.0毫克PGE2,其余70名患者仅接受该剂量的一半,即0.5毫克。无论剂量如何,超过60%的患者在不到24小时内无需进一步刺激即被诱导分娩。平均诱导分娩时间为10小时。在其余患者中,宫颈出现了明显成熟。1名接受1.0毫克PGE2的患者确实出现了子宫收缩过强,除此之外未观察到母体副作用。对胎儿无不良影响。器械助产率为19%,其中剖宫产率为9%。结论是,局部应用PGE2凝胶可用于使足月宫颈未成熟的患者宫颈成熟和/或诱导分娩。由于两剂量之间在有效性方面实际无差异,但接受1.0毫克PGE2的患者中有1例出现子宫过度刺激,因此推荐较小剂量,即0.5毫克。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验